# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-047562
Filing Date
2024-04-24
Accepted
2024-04-24 16:02:04
Documents
6
Period of Report
2024-06-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | bcab_def_14a_2024_no_xbr.htm | DEF 14A | 981844
2 | GRAPHIC | img177385329_0.jpg | GRAPHIC | 67487
3 | GRAPHIC | img177385329_1.jpg | GRAPHIC | 41244
4 | GRAPHIC | img177385329_2.jpg | GRAPHIC | 43646
5 | GRAPHIC | img177385329_3.jpg | GRAPHIC | 771336
6 | GRAPHIC | img177385329_4.jpg | GRAPHIC | 449407
| Complete submission text file | 0000950170-24-047562.txt |  | 2874113

Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

EIN.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39787 | Film No.: 24870499
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)